You are on page 1of 1

r-ct›-t»-n*

Curr’lcu1um Vitae for Invcsiigator

Prcsei›t Aj›pointnicni: Study Vaccinatnr

Name of Institution A Deyartmeftl:


Pnndnk Sukatani indah huusiny t›Iock yell 5 rt, 00'i/004 kcl.
Sukatarti. Raje8
Contact (Tel . L-mail & Mobilc):

hJcdical Reference/I.tCCftCC ftuftlber: I l02322224218350

EdycBtion (7olleye, tJnixersilics. Traininjt)


Other
Name of Institution From Tn Degree

lJusada hlidwifery academy 2013 2015 Midaifct} I3iplnma

PrexJous Appointments

MamsoflnstituWon Tram To

Puskcsmns h4auk hlid* ife 200'i >• s oing

Research Experience
A Global, Multi-center, Randomized, Double-Blind, Placebo-controlled, Phase III Clinical Study to
Evaluate the Protective Efficacy, Safety and lmmunogenicity of 5ARS-CoV-2 Messenger
Ribonucleic Acid (mRNA) Vaccine in Population Aged 18 Years and Older (Ongoing)
Year o£GCP Training

202 I

Professional Societies or Organizations (Most Reles'onl)

Publications (Appropriate Box)

6-10 I 1-20

Dale of Signature: '

C‘unfdenrinl Pay I of I
SOPs Li L. SOP-CD-01

You might also like